Skip to main content
  • Offering
    • Offering
    • Integrated Biologics
      • Integrated Biologics
      • Expression Technologies
        • Expression Technologies
        • GS Xceed® Gene Expression System
        • GS piggyBac® Transposon Technology
        • GS Effex® Cell Line
        • GS Discovery® Transient Expression
        • bYlok® Bispecific Pairing Technology
        • XS Technologies® Platform
        • Technical Support
      • Early Drug Development Services
        • Early Drug Development Services
        • Developability Assessment
        • Manufacturability Assessment
        • Biologics Formulatability
        • Immunogenicity / Immunotoxicity Assessment
        • ​​Early Protein Expression​​​ Services​​
      • Integrated DNA-to-IND Programs
        • Integrated DNA-to-IND Programs
        • mAbs DNA-to-IND Program
        • Bispecifics DNA-to-IND Program
        • Fab Fragments DNA-to-IND Program
        • Fc-Fusion Proteins DNA-to-IND Program
        • Scaffolds and other Recombinant Proteins DNA-to-IND Programs
      • Development Services
        • Development Services
        • Biologics Process Development
        • Biologics Analytical Development
        • Formulation and Primary Packaging Development
      • Manufacturing
        • Manufacturing
        • Mammalian Drug Substance Manufacturing
        • Drug Product Manufacture
        • OptiALTO® Intensified Fed-Batch Platform
      • Mammalian Biopharmaceutical Services
        • Mammalian Biopharmaceutical Services
        • Cell Line Development
        • Tailored License Application Program
        • Process Development
      • Drug Product Services
      • Biologics Regulatory Affairs
      • Knowledge Center
    • Advanced Synthesis
      • Advanced Synthesis
      • Small Molecules
        • Small Molecules
        • Drug Substance/API Services
          • Drug Substance/API Services
          • Lonza Design2Optimize® Services
          • Early Phase Small Molecule Development Services
          • API Support for Early Phase Development
          • AI-Enabled Route Scouting Service
          • Solid Form Drug Services
          • PBPK Modeling Services
          • High-Throughput Experimentation Service
          • Pharmaceutical Method Development
          • Commercial API Manufacturing Services
          • Highly Potent API Technologies
            • Highly Potent API Technologies
            • HPAPI Handling and Development
            • HPAPI Manufacturing | Low & High Potency
        • Bioavailability Enhancement
          • Bioavailability Enhancement
          • Amorphous Solid Dispersion Technology
          • Spray-Dried Dispersion Technology
          • Hot Melt Extrusion
        • Drug Product
          • Drug Product
          • Clinical Trial Material Manufacture, Supply
          • Formulation and Development
          • Design and Preformulation Development
          • Drug Development Workflow & Pharmaceutical Process Optimization
          • Inhalation Formulation Development
          • Integrated Offerings
        • Regulatory Affairs CMC Services
          • Regulatory Affairs CMC Services
          • CMC Development Services | CMC Regulatory Submissions
      • Bioconjugation Services
        • Bioconjugation Services
        • Early Development Bioconjugate Services | ADCs
        • Drug Substance Manufacturing & Bioconjugates Production | Lonza
        • Pharmaceutical, ADC Analytical Services
        • Targeting Agent and Carrier Protein
        • ADC Process Development
        • DNA-to-IND program for ADCs
        • ADC Clinical and Commercial Manufacturing
        • ADC Payload Product Development
      • ADC Technologies Platform
      • Knowledge Center
    • Specialized Modalities
      • Specialized Modalities
      • Cell & Gene
        • Cell & Gene
        • Process Development
        • cGMP Manufacturing
        • Allogeneic
        • Autologous
        • Viral Vectors
        • Exosomes
      • Microbial
        • Microbial
        • Microbial Strain Development
        • Process Development
        • Drug Substance Manufacturing
        • Analytical Development
      • mRNA/LNP
        • mRNA/LNP
        • Process Development
        • Analytical Services
        • mRNA Manufacturing
        • Lipid Nanoparticles Encapsulation
      • Bioscience Products
      • Knowledge Center
    • Knowledge Center
  • Company
    • Company
    • About Us
      • About Us
      • Our One Lonza Strategy
      • Our Leadership
        • Our Leadership
        • Executive Committee
        • Board of Directors
        • Board Committees
      • Our History
      • Our Locations
    • News and Media
      • News and Media
      • News Releases
      • Images and Videos
      • Logo Guidelines
      • Blog
      • A View On - Lonza Podcast
      • Journalist Inquiries
    • Investor Relations
      • Investor Relations
      • Shareholder and Bondholder Information
        • Shareholder and Bondholder Information
        • Consensus and Analysts
        • Bond Investors and Credit Information
        • Investor FAQ
        • Share Buyback
      • Agenda and Events
      • Reporting and Presentations
      • Corporate Governance
      • Ethics and Compliance
      • Investor Inquiries and Feedback
    • Sustainability
      • Sustainability
      • Environment
      • People and Society
      • Compliance and Integrity
      • Responsible Sourcing
      • Global Quality
  • Careers
    • Careers
    • Welcome to Lonza
    • Place of Unique Opportunity
    • Opportunity That Grows with You
    • A Place to Belong
    • Join Our Talent Community
  • Contact Search
  • Cancel
Update website images_4

New and Upcoming Events

Filter Results
Filter Results
Filter by Offering
Advanced Synthesis (1) Corporate (1) Integrated Biologics (1)
Filter by Content Type
Conference (1) Webinar (1)
Filter by Country
Saudi Arabia (1) United States of America (1)
   Loading...
Showing 1‐3 of 3
Advanced Synthesis
Webinar: Advancing Next-Generation ADCs: Clinical Insights from the GlycoConnect® Platform & Expansion of Lonza's toxSYN® Platform
18 Nov 2026 | Online
Discover how Lonza’s innovative GlycoConnect® technology, HydraSpace® technology, and toxSYN® technology are helping to shape the next generation of differentiated ADCs designed to improve the therapeutic index and unlock new possibilities in targeted med...
Integrated Biologics
Antibody Engineering & Therapeutics
13 Dec 2026 - 16 Dec 2026 | San Diego, US
Meet with, and learn from, pioneers in the antibody industry. The Society hosts educational webinars and Symposia, and serves as the home for the Adaptive Immune Receptor Repertoire (AIRR) Community, which focuses on the generation, use, sharing and stand...
Corporate
CPHI Middle East
14 Dec 2026 - 16 Dec 2026 | Malham, SA
Extensive networking, direct market access, latest insights on regulatory developments and pharmaceutical innovations, and a comprehensive range of products and services spanning the entire pharmaceutical supply chain.
Who we are
  • Company Overview
  • News & Media
  • Investor Relations
  • Sustainability
  • Careers
Quick Links
  • Reporting Center
  • Upcoming Events
  • Knowledge Center
  • Meet The Experts
  • Our Locations
  • California CCPA Notice
  • Transparency in Coverage
Get in touch
  • Contact Us
  • Regulatory Support
© 2026 Lonza. All rights reserved.
Cookie Settings | Terms and Conditions | Legal Disclaimer | Privacy Policy | Accessibility | Sitemap